系统性红斑狼疮中的原发性头痛——系统综述与荟萃分析
该系统综述与荟萃分析纳入11篇论文,发现狼疮患者原发性头痛的合并患病率为26.8%(95%CI 25.1-28.6),与健康对照相似(OR 2.14,95%CI 0.97-4.76,P=0.06),但高于类风湿关节炎和原发性干燥综合征患者(OR 2.5,95%CI 1.56-4,P<0.0001)。原发性头痛似乎与抑郁和健康相关生活质量受损相关,而非与狼疮活动性或损伤相关;「狼疮头痛」是罕见表现。
要点
- 狼疮患者原发性头痛合并患病率26.8%(95%CI 25.1-28.6)。
- 狼疮患者原发性头痛与健康对照无显著差异(OR 2.14,95%CI 0.97-4.76,P=0.06),但Egger检验提示发表偏倚显著。
- 「狼疮头痛」在SLICC队列中仅占1.5%,为罕见表现,需排除其他原因后考虑。
核心结论
- 狼疮患者原发性头痛及偏头痛的患病率似乎与健康对照相似。
- 这些原发性头痛与抑郁和雷诺现象相关,而与疾病活动性或损伤无关。
- 关于原发性头痛相关结构改变的数据 scarce。
- 目前「狼疮头痛」似乎是狼疮一种 distinct 罕见表现,需要更多数据。
研究设计与样本
- 遵循PRISMA指南的系统综述与荟萃分析,检索Ovid Medline、Embase、PsycINFO和Cochrane系统综述数据库自建库至2022年4月,仅纳入2004年及以后发表的论文。
- 共识别5096篇参考文献,189篇进入详细审阅,最终11篇论文纳入分析。
- 使用漏斗图评估统计与发表偏倚。
主要发现
- 狼疮患者原发性头痛合并患病率为26.8%(95%CI 25.1-28.6)。
- 狼疮患者与健康对照的原发性头痛患病率相似,OR 2.14(95%CI 0.97-4.76,P=0.06),但Egger检验提示发表偏倚显著。
- 狼疮患者原发性头痛患病率似乎高于类风湿关节炎和原发性干燥综合征患者,OR 2.5(95%CI 1.56-4,P<0.0001)。
- 偏头痛患病率在狼疮患者与健康对照及类风湿关节炎或原发性干燥综合征患者之间均未发现差异。
- 一项MRI研究提示较大的灰质体积降低头痛总体 odds(OR 0.98,P=0.048)和偏头痛 odds(OR 0.95,P=0.004),较大的白质体积增加偏头痛 odds(OR 1.04,P=0.007)。
关键数值与推荐
- 原发性头痛与抑郁和健康相关生活质量受损相关,而非与狼疮活动性或损伤相关。
- 数据不足以断定特定狼疮治疗是否影响原发性头痛,但一项研究提示羟氯喹减少原发性头痛频率。
- 雷诺现象与偏头痛相关。
- Hanly 2013年SLICC队列研究显示仅1.5%患者有「狼疮头痛」(按SLEDAI-2K定义)。
临床怎么用
- 「狼疮头痛」是SLE中的罕见 entity,应在排除头痛其他可能原因后怀疑,尤其当无已知原发性头痛病史时。
局限性
- Egger检验提示发表偏倚显著。
- 数据不足以断定特定狼疮治疗是否影响原发性头痛。
- 关于原发性头痛相关结构改变的数据 scarce。
- MRI发现可能反映疾病活动性或损伤,因此需要进一步研究以澄清该问题。
- 目前「狼疮头痛」似乎是 distinct 罕见表现,需要更多数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To systematically review and synthesize literature on: 1) the overall prevalence of primary headaches and specifically migraines, in patients with lupus since previous systematic review published in 2004; 2) the risk factors associated with primary headaches in patients with lupus; 3) the association of primary headaches with structural brain changes; and 4) "lupus headaches". METHODS: This review used (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) PRISMA guidelines and literature searches in four databases: Ovid-based Medline, Embase, PsycINFO, and Cochrane Database of Systematic Reviews from inception until 4/2022. Papers on primary headaches in patients with lupus were identified. Included studies were critically appraised and analyzed. Since a systematic review on this topic was published in 2004, only papers published in 2004 and later were included in this review. Statistical and publication bias was assessed using funnel plots. RESULTS: A total of 5096 references were identified, 189 were selected for detailed review and 11 papers were included in the final analysis. 1) The pooled prevalence of primary headaches in lupus was 26.8 % (95 %CI 25.1-28.6). The prevalence of primary headaches was similar between patients with lupus and healthy controls, odds ratio (OR) 2.14, 95 %CI 0.97-4.76, p value=0.06, however publication bias was significant according to the Egger test. Lupus patients seem to have a higher prevalence of primary headaches compared to patients with rheumatoid arthritis (RA) and primary Sjogren's syndrome (pSS), OR 2.5, 95 % CI 1.56-4, p < 0.0001. Regarding the prevalence of migraines specifically, no difference was found between patients with lupus compared to healthy controls and patients with RA or pSS. 2) Primary headaches seem to be associated with depression and impaired health related quality of life rather than lupus activity or damage. There is insufficient data to conclude whether specific lupus treatments affected primary headaches in lupus, however, one study did suggest hydroxychloroquine reduced the frequency of primary headaches. Raynaud phenomenon was associated with migraines. 3) One study which examined MRI scans of patients with lupus compared to healthy controls did suggest that larger gray matter volumes reduced the odds for headaches in general (OR 0.98, p = 0.048) and for migraines in particular (OR 0.95, p = 0.004), and larger white matter volumes increased the odds for migraine (OR 1.04, p = 0.007). However, these findings might reflect disease activity or damage, therefore further studies are required to clarify this issue. 4) The only study which specifically addressed the prevalence of "lupus headaches" is Hanly's study from 2013 of the SLICC cohort. In this large cohort, only 1.5 % of patients had "lupus headaches", as defined by SLE Disease Activity Index-2000 (SLEDAI-2 K). Therefore "Lupus headache" is a rare entity in SLE and should be suspected after excluding other possible explanations for headaches, especially when there is no known prior history of primary headaches. CONCLUSIONS: Patients with lupus seem to have a similar prevalence of primary headaches, and specifically migraines, compared to healthy controls. These primary headaches are associated with depression and Raynaud phenomenon and not with disease activity nor damage. Scarce data is published regarding structural changes associated with primary headaches. Currently is seems "lupus headaches" are a distinct rare manifestation of lupus and more data are needed.
引用
- Feld J, Tayer-Shifman OE, Su J, et al. Primary headache in SLE -systematic review and meta-analysis. Semin Arthritis Rheum. 2024. PMID: 39476557. doi:10.1016/j.semarthrit.2024.152566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。